Novel approach reveals underlying neuroscience of patient decision-making

NewsGuard 100/100 Score

Mind Field Solutions kicked off the 2012 AHRQ lecture series with what's been described as a "Stunning Innovation in Healthcare" by one of the nation's leading academic clinical centers. The lecture on the 'Cognitive Architecture™ of Patient Engagement and Implications for Healthcare Outcomes and Costs' presented a novel approach that reveals the underlying neuroscience of patient decision-making. iPhone/iPad HIT that can diagnose which patients will disengage from treatment were showcased. The new approach also provides a neuroscientific explanation of the underlying causes behind patient disengagement. Harvard's Dana-Farber, who has also been presented with the findings, have described it as "a scientific approach to patient care that is long overdue."

The HIT apps work at an individual patient level to allow for targeted and patient-centric communications via avatars that are personalized on the users handheld devices. "We are excited about the potential that this innovation brings to healthcare delivery, outcomes and cost. Healthcare has suffered greatly due to the inability to effectively and efficiently engage patients in their self-care. This research provides a scientific framework for engagement that creates significant impact in outcomes and cost. Our data suggests a cost savings of $3billion per annum for Medicare diabetes alone," says neuroscientist, Dr LaFountain, CEO and Founder of Mind Field Solutions.

SOURCE Mind Field Solutions

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research highlights complexity of xylazine and fentanyl combination in overdose cases